Abstract
Background We sought to determine temporal trends in use of evidence-based therapies and clinical outcomes among myocardial infarction ( MI) patients with chronic kidney disease ( CKD ). Methods and Results MI patients from the NCDR (National Cardiovascular Data Registry) Chest Pain- MI Registry between January 2007 and December 2015 were categorized into 3 groups by degree of CKD (end-stage renal disease on dialysis, CKD [glomerular filtration rate <60 mL/min per 1.73 m(2)] not requiring dialysis, and no CKD [glomerular filtration rate ≥60 mL/min per 1.73 m(2)]). Logistic regression modeling was used to determine the association between calendar years (2014-2015 versus 2007-2008) and each outcome by degree of CKD . Among 325 396 patients with ST-segment-elevation MI, 1.0% had end-stage renal disease requiring dialysis, and 26.1% had CKD not requiring dialysis. Use of primary percutaneous coronary intervention increased over time regardless of the presence or degree of CKD ( P=0.40 for interaction). In-hospital mortality was temporally higher among patients with preserved renal function (odds ratio: 1.25; 95% confidence interval, 1.13-1.39; P<0.001) but not among patients with CKD ( P=0.035 for interaction). Among 506 876 non-ST-segment-elevation MI patients, 3.4% had end-stage renal disease requiring dialysis, and 34.4% had CKD not requiring dialysis. P2Y(12) inhibitor use within 24 hours increased over time only among dialysis patients ( P for interaction <0.001). Use of coronary angiography and percutaneous coronary intervention also increased, with the greatest increase among dialysis patients ( P for interaction <0.001 and <0.001, respectively). In-hospital mortality was lower, regardless of the presence or degree of CKD ( P=0.64 for interaction). Conclusions Uptake of evidence-based medical and invasive therapies has increased over the past decade among MI patients with CKD , particularly dialysis patients, with improvement of in-hospital mortality observed among patients with non-ST-segment-elevation MI, but not ST-segment-elevation MI, and CKD .